Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Research

Associations of Serum Concentrations of 25-Hydroxyvitamin D and Parathyroid Hormone With Surrogate Markers of Insulin Resistance Among U.S. Adults Without Physician-Diagnosed Diabetes: NHANES, 2003–2006

  1. Guixiang Zhao, MD, PHD,
  2. Earl S. Ford, MD, MPH and
  3. Chaoyang Li, MD, PHD
  1. From the Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
  1. Corresponding author: Guixiang Zhao, gzhao{at}cdc.gov.
Diabetes Care 2010 Feb; 33(2): 344-347. https://doi.org/10.2337/dc09-0924
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE To examine whether concentrations of serum 25-hydroxyvitamin D (25[OH]D) and parathyroid hormone (PTH) are associated with surrogate markers of insulin resistance (IR) in U.S. adults without physician-diagnosed diabetes.

RESEARCH DESIGN AND METHODS Cross-sectional data (n = 3,206) from the National Health and Nutrition Examination Survey (NHANES) 2003–2006 were analyzed.

RESULTS The age-adjusted prevalence of hyperinsulinemia, high homeostasis model assessment-IR, high GHb, and fasting and 2-h hyperglycemia decreased linearly across quintiles of 25(OH)D but increased linearly across quintiles of PTH (except for a quadratic trend for fasting hyperglycemia). After extensive adjustment for potential confounders, the relationships between 25(OH)D and the markers of IR and 2-h hyperglycemia persisted. Only hyperinsulinemia was positively associated with PTH (P < 0.05).

CONCLUSIONS Among U.S. adults without physician-diagnosed diabetes, low concentrations of serum 25(OH)D were associated with markers of IR. The role of PTH in IR deserves further investigation.

The role of vitamin D and parathyroid hormone (PTH) in metabolic syndrome and diabetes is receiving increased attention. Insulin resistance (IR) may represent a potential mechanism linking vitamin D and PTH to these conditions. The inverse associations between vitamin D and fasting insulin concentrations or the homeostasis model assessment of IR (HOMA-IR) index have been reported in some (1–5) but not all studies (6). Moreover, evidence linking PTH to markers of IR is limited and inconsistent (7–9). This study examined whether serum 25-hydroxyvitamin D (25[OH]D) and PTH are associated with surrogate markers of IR in U.S. adults without physician-diagnosed diabetes.

RESEARCH DESIGN AND METHODS

We used data from the National Health and Nutrition Examination Survey (NHANES) 2003–2006. Participants who were aged ≥20 years, attended the morning examination after fasting ≥8 h, and had not been diagnosed with diabetes were included as were participants with undiagnosed diabetes (fasting glucose ≥126 mg/dl or GHb ≥6.5%) (10). Serum 25(OH)D concentrations were measured using a radioimmunoassay procedure. Serum PTH concentrations were measured on the Elecsys 1010 analyzer using an electrochemiluminescent procedure. The quintiles of 25(OH)D and PTH were created after taking into account the sampling weights.

Plasma concentrations of fasting and 2-h glucose, fasting insulin, and GHb were adjusted for differences in laboratory methodology between NHANES 2003–2004 and 2005–2006. Oral glucose tolerance test data were available only for NHANES 2005–2006. We defined fasting hyperglycemia as a fasting glucose ≥100 mg/dl, 2-h hyperglycemia as a 2-h glucose ≥140 mg/dl, and high GHb as a value of ≥6.0%. HOMA-IR index was calculated as (fasting plasma insulin [mU/l] × fasting plasma glucose [mmol/l])/22.5. Hyperinsulinemia and high HOMA-IR were defined using the weighted 75th percentiles.

Covariates in our analyses included age, sex, race/ethnicity, education, smoking, physical activity, alcohol drinking, BMI, abdominal obesity, and serum calcium concentrations. From 3,551 participants without physician-diagnosed diabetes, 3,206 (1,582 male subjects and 1,624 female subjects) remained in our analyses after excluding those who had missing values for study variables. The prevalence of surrogate markers of IR was age-standardized to the 2000 U.S. population. Linear trends across quintiles of 25(OH)D and PTH were tested using orthogonal contrasts in SUDAAN software. Multiple logistic regression analyses were conducted to test associations of 25(OH)D or PTH with markers of IR.

RESULTS

Among 3,206 participants, 118 had undiagnosed diabetes. The age-adjusted prevalence was 5.7% (95% CI 4.8–6.7%) for high GHb, 30.6 (27.8–33.6) for fasting hyperglycemia, and 20.4 (17.7–23.4) for 2-h hyperglycemia. The prevalence of all outcome measures and the multivariate-adjusted odds ratios (ORs) for hyperinsulinemia, high HOMA-IR, high GHb, and 2-h hyperglycemia decreased linearly across quintiles of 25(OH)D (P < 0.05 for all) (Table 1). After excluding participants without physician-diagnosed diabetes but who had diabetes based on fasting glucose or GHb values, similar results were observed except the significant association between high GHb and 25(OH)D disappeared.

View this table:
  • View inline
  • View popup
Table 1

Age-adjusted prevalence and adjusted ORs (95% CIs) of the surrogate markers of IR by quintiles of serum 25(OH)D and PTH concentrations among U.S. adults aged ≥20 years without physician-diagnosed diabetes, NHANES 2003–2006 (n = 3,206)*

Interactions between race/ethnicity and 25(OH)D for outcome measures were not significant in the full models.

The prevalence of hyperinsulinemia, high HOMA-IR, high GHb, and 2-h hyperglycemia increased linearly, and the prevalence of fasting hyperglycemia increased nonlinearly across quintiles of PTH. After adjusting for demographic and lifestyle factors, the ORs for hyperinsulinemia, high HOMA-IR, and high GHb were significantly higher in the highest than in the lowest quintile of PTH, and significantly increasing trends existed for all measures except for 2-h hyperglycemia. After further adjusting for all potential confounders, most of the associations lost statistical significance; only an increasing trend for hyperinsulinemia across quintiles of PTH persisted (P < 0.05). These results did not change much after excluding participants without physician-diagnosed diabetes but who had diabetes based on fasting glucose or GHb values.

CONCLUSIONS

Our findings of an inverse association between 25(OH)D and IR among adults without physician-diagnosed diabetes are consistent with previous findings from cross-sectional (1–4) and prospective (5) studies. These results offer further support that lower concentrations of 25(OH)D may be a predictor of increased likelihood of diabetes in the population (11–14).

Compared with previous studies that examined the associations of 25(OH)D with IR (1–4), an advantage of our study was that we were able to simultaneously examine the associations between serum 25(OH)D and PTH—both of which play an essential role in regulating calcium homeostasis—and IR. In addition, we were able to adjust for overall obesity (i.e., BMI) and abdominal obesity, which were strong confounders for the analyses. The expression of vitamin D receptors in both pancreatic β-cells and skeletal muscle cells, which, upon activation by vitamin D supplementation, result in increased insulin release and responsiveness to insulin for glucose transport (14), may serve as an underlying mechanism.

Our results regarding possible racial/ethnic disparities in the associations of 25(OH)D with IR conflict with those from Scragg et al. (3). Given the high proportion of African Americans with vitamin D deficiency or insufficiency, the issue of possible racial/ethnic disparities deserves further investigation (15).

Primary hyperparathyroidism was associated with impaired glucose tolerance, insulin insensitivity, and diabetes (7). However, a significant correlation between PTH and HOMA-IR was observed in adults aged 70 years with an average BMI of 27 kg/m2 (8), but not in middle-aged, morbidly obese adults (average BMI 44.7 kg/m2) (9). These studies were conducted in selected populations, and the data analyses did not adequately control for potential confounders. Our study, based on a nationally representative sample, showed a significant association between PTH and hyperinsulinemia after adjusting for potential confounders. However, analyses limited to participants with concentrations of 25(OH)D <30 ng/ml (n = 2,518), a point at which PTH concentrations begin to increase, revealed no associations between PTH and hyperinsulinemia or HOMA-IR.

Our study was limited by the inability to establish the causality between 25(OH)D and IR based on our cross-sectional study and by the inability to account for sunlight exposure due to lack of data.

In conclusion, low concentrations of 25(OH)D were associated with markers of IR among U.S. adults without physician-diagnosed diabetes. Future prospective studies and intervention trials are needed to confirm the associations of 25(OH)D with IR and to further investigate the role of PTH in IR.

Acknowledgments

No potential conflicts of interests relevant to this article were reported.

Footnotes

  • The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Received May 20, 2009.
    • Accepted October 13, 2009.
  • Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

  • © 2010 by the American Diabetes Association.

References

  1. ↵
    1. Liu E,
    2. Meigs JB,
    3. Pittas AG,
    4. McKeown NM,
    5. Economos CD,
    6. Booth SL,
    7. Jacques PF
    . Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139: 329– 334
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Lu L,
    2. Yu Z,
    3. Pan A,
    4. Hu FB,
    5. Franco OH,
    6. Li H,
    7. Li X,
    8. Yang X,
    9. Chen Y,
    10. Lin X
    . Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278– 1283
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Scragg R,
    2. Sowers M,
    3. Bell C
    . Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813– 2818
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Chiu KC,
    2. Chu A,
    3. Go VL,
    4. Saad MF
    . Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820– 825
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Forouhi NG,
    2. Luan J,
    3. Cooper A,
    4. Boucher BJ,
    5. Wareham NJ
    . Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 2008; 57: 2619– 2625
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Gannagé-Yared MH,
    2. Chedid R,
    3. Khalife S,
    4. Azzi E,
    5. Zoghbi F,
    6. Halaby G
    . Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 2009; 160: 965– 971
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Khaleeli AA,
    2. Johnson JN,
    3. Taylor WH
    . Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabete Metab Res Rev 2007; 23: 43– 48
    OpenUrlCrossRef
  8. ↵
    1. Ahlstrom T,
    2. Hagstrom E,
    3. Larsson A,
    4. Rudberg C,
    5. Lind L,
    6. Hellman P
    . Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol (Oxf) 2009; 71: 673– 678
    OpenUrlCrossRefPubMed
  9. ↵
    1. Hjelmesaeth J,
    2. Hofso D,
    3. Aasheim ET,
    4. Jenssen T,
    5. Moan J,
    6. Hager H,
    7. Roislien J,
    8. Bollerslev J
    . Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009; 8: 7– 13
    OpenUrlCrossRefPubMed
  10. ↵
    International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327– 1334
    OpenUrlFREE Full Text
  11. ↵
    1. Knekt P,
    2. Laaksonen M,
    3. Mattila C,
    4. Harkanen T,
    5. Marniemi J,
    6. Heliovaara M,
    7. Rissanen H,
    8. Montonen J,
    9. Reunanen A
    . Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008; 19: 666– 671
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Pittas AG,
    2. Dawson-Hughes B,
    3. Li T,
    4. Van Dam RM,
    5. Willett WC,
    6. Manson JE,
    7. Hu FB
    . Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650– 656
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Ford ES
    . Vitamin supplement use and diabetes mellitus incidence among adults in the United States. Am J Epidemiol 2001; 153: 892– 897
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Borissova AM,
    2. Tankova T,
    3. Kirilov G,
    4. Dakovska L,
    5. Kovacheva R
    . The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57: 258– 261
    OpenUrlPubMedWeb of Science
  15. ↵
    1. Ginde AA,
    2. Liu MC,
    3. Camargo CA Jr
    . Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 2009; 169: 626– 632
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 33 (2)

In this Issue

February 2010, 33(2)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Associations of Serum Concentrations of 25-Hydroxyvitamin D and Parathyroid Hormone With Surrogate Markers of Insulin Resistance Among U.S. Adults Without Physician-Diagnosed Diabetes: NHANES, 2003–2006
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Associations of Serum Concentrations of 25-Hydroxyvitamin D and Parathyroid Hormone With Surrogate Markers of Insulin Resistance Among U.S. Adults Without Physician-Diagnosed Diabetes: NHANES, 2003–2006
Guixiang Zhao, Earl S. Ford, Chaoyang Li
Diabetes Care Feb 2010, 33 (2) 344-347; DOI: 10.2337/dc09-0924

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Associations of Serum Concentrations of 25-Hydroxyvitamin D and Parathyroid Hormone With Surrogate Markers of Insulin Resistance Among U.S. Adults Without Physician-Diagnosed Diabetes: NHANES, 2003–2006
Guixiang Zhao, Earl S. Ford, Chaoyang Li
Diabetes Care Feb 2010, 33 (2) 344-347; DOI: 10.2337/dc09-0924
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Research

  • Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
  • Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
  • Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58
Show more Original Research

Epidemiology/Health Services Research

  • Productivity Benefits of Preventing Type 2 Diabetes in Australia: A 10-Year Analysis
  • Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study
  • Insulinemic and Inflammatory Dietary Patterns Show Enhanced Predictive Potential for Type 2 Diabetes Risk in Postmenopausal Women
Show more Epidemiology/Health Services Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.